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Background: Colorectal cancer is the second most common cancer and cancer-killer in Hong Kong with an
alarming increasing incidence in recent years. The latest World Cancer Research Fund report concluded that foods
low in fibre, and high in red and processed meat cause colorectal cancer whereas physical activity protects against
colon cancer. Yet, the influence of these lifestyle factors on cancer outcome is largely unknown even though
cancer survivors are eager for lifestyle modifications. Observational studies suggested that low intake of a
Western-pattern diet and high physical activity level reduced colorectal cancer mortality. The Theory of Planned
Behaviour and the Health Action Process Approach have guided the design of intervention models targeting a
wide range of health-related behaviours.
Methods/design: We aim to demonstrate the feasibility of two behavioural interventions intended to improve
colorectal cancer outcome and which are designed to increase physical activity level and reduce consumption of a
Western-pattern diet. This three year study will be a multicentre, randomised controlled trial in a 2x2 factorial
design comparing the “Moving Bright, Eating Smart” (physical activity and diet) programme against usual care.
Subjects will be recruited over a 12-month period, undertake intervention for 12 months and followed up for a
further 12 months. Baseline, interim and three post-intervention assessments will be conducted.
Two hundred and twenty-two colorectal cancer patients who completed curative treatment without evidence of
recurrence will be recruited into the study. Primary outcome measure will be whether physical activity and dietary
targets are met at the end of the 12-month intervention. Secondary outcome measures include the magnitude and
mechanism of behavioural change, the degree and determinants of compliance, and the additional health benefits
and side effects of the intervention.
Discussion: The results of this study will establish the feasibility of targeting the two behaviours (diet and physical
activity) and demonstrate the magnitude of behaviour change. The information will facilitate the design of a further
larger phase III randomised controlled trial with colorectal cancer outcome as the study endpoint to determine
whether this intervention model would reduce colorectal cancer recurrence and mortality.
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Colorectal cancer, treatment outcome and lifestyle factors
According to the Hong Kong Cancer Registry [1], colo-
rectal cancer (CRC) was the second most common can-
cer and the second highest cancer-killer in Hong Kong
with 4,370 new cases and 1,864 deaths in 2010, respec-
tively. Moreover, the crude incidence rate of CRC in-
creased from 48.2 per 100,000 in 2000 to 62.2 per
100,000 in 2010 [1]. CRC may soon become the most
common cancer in Hong Kong. This alarming trend is
mirrored in many Asian countries [2].
The latest report of the World Cancer Research Fund
(WCRF) [3] summarises convincing evidence from pub-
lished observational studies that physical activity (PA)
protects against colon cancer (CC) while foods low in
dietary fibre, high in red and processed meat, high levels
of alcohol drinking in men, body fatness, abdominal fat-
ness and factors leading to greater adult attained height
cause CRC. However, the influence of these lifestyle fac-
tors on the outcome of patients with established CRC is
largely unknown.
With advances in treatment, CRC survivors are now
living longer. Many of them are highly motivated to seek
information about lifestyle modifications that improve
quality of life and increase their chance of prolonged life
and recovery from cancer. Although evidence on certain
aspects of PA or diet specifically affecting health out-
comes in cancer survivors is emerging, it is not yet suffi-
ciently established to allow firm recommendations to be
made [4].
The observational Nurses’ Health Study showed that
recreational PA reduced cancer-specific and overall mor-
tality for stage I to III female CRC patients [5], while in
another observational study [6], maintaining weekly PA
levels over 18 metabolic-equivalent-hours (MET-hours)
reduced recurrence and mortality in stage III CC after
adjuvant chemotherapy.
A recent observational study compared cancer outcome
of stage III CC in two dietary groups [7]. Compared with
patients with the lowest mean intake of a Western-pattern
diet (i.e., 2.3 servings of red meat weekly, 1.8 servings of
processed meat weekly, 2.0 servings of refined grains daily,
and less than 1 serving of sugary desserts daily), those with
the highest mean intake (i.e., 6 servings of red meat weekly,
5.6 servings of processed meat weekly, 5.8 servings of
refined grains daily, and 2.5 servings of sugary desserts
daily) had an adjusted hazard ratio for death of 3.25 (95%confidence interval 2.04-5.19). No association was found of
a prudent dietary pattern (i.e., high intakes of fruit, vege-
table, poultry and fish) with CC mortality and recurrence.
Moreover, the two patterns were not inter-correlated
(Spearman correlation 0.02).
Our literature review identified a small number of pub-
lished randomised controlled trials (RCT) or feasibility
studies [8-12] on lifestyle intervention of CRC survivors.
No CRC intervention has been conducted in an Asian
population. Furthermore, to date, there are no published
data regarding the effect of PA and/or dietary interventions
on CRC outcomes.
Theories on health behaviour
The Theory of Planned Behaviour (TPB) [13] is one of the
most widely tested theories explaining and predicting in-
tentions to perform a wide range of health-related behav-
iours [14-18]. The TPB has been the framework for the
design of intervention models targeted at health behaviour
change [19,20] and posits that an individual’s behaviour is
predicted by his/her intention to perform the behaviour.
This behavioural intention is, in turn, determined by atti-
tudes towards the behaviour, subjective norms, and per-
ceived behavioural control, with each of these being the
result of beliefs. The likelihood that an individual’s inten-
tion to adopt a health behaviour will therefore be in-
creased if he holds a more favourable attitude towards the
behaviour (behavioural beliefs), believes that significant
others want him to adopt the behaviour (normative be-
liefs), and perceives that the behaviour is under his control
(control beliefs). The three sets of belief constructs can
thus be targeted by interventions for health behaviour
change. Useful as the TPB is, it is important to note
that intentions to behave do not necessarily lead to actual
performance of behaviours. The discrepancy between in-
tended and actual behaviours is termed the intention-
behaviour gap [21].
The Health Action Process Approach (HAPA) [22] inte-
grates social-cognitive theory [23], the theory of reasoned
action [24] and the volition theories [25,26]. HAPA is par-
ticularly useful in guiding the development and design
of intervention aimed to enhance health self-regulation
[27] that involves motivation, volitional, and actional pro-
cesses of abandoning health-compromising behaviours
and adopting and maintaining health-enhancing behav-
iours [28]. The model addresses the intention-behaviour
gap and defines ways to identify and modify the factors
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model categorizes health behavioural changes into two
stages (processes): the pre-intentional motivation process
and the post-intentional volition process, with the first
process leading to behavioural intention and the second
to actual health behaviours [27]. After a person has an
intention to act, he/she needs detailed instructions on how
to perform the desired action and the perceived self-
efficacy to initiate and to maintain the action. All these
require self-regulatory skills and strategies such as action
planning [22]. Interventions for changing health behaviours
can target attitudes, perceived barriers, personal vulnerabil-
ity and perceived self-efficacy, however, only stage-matched
conditions can bring about benefits on the participants.
For example, only intenders and actors will benefit from
self-regulatory efforts.
Study objectives
Based on the TPB and HAPA, this study aims to evaluate
the acceptability and feasibility of two behavioural inter-
ventions on CRC survivors intended to improve cancer
outcome and are designed to increase PA levels and
reduce consumption of a Western-pattern diet (i.e., high
intake of red and processed meat, dietary fat, refined
grains and sugary desserts) [7,29].
Methods/design
Ethical approval for the study has been received from
the Institutional Review Board of the Hong Kong West
Cluster, the Hospital Authority in Hong Kong (see later).
All participants will receive a written participant infor-
mation sheet explaining the trial and all will be asked to
give written consent prior to participation.
Study/trial design
This will be a three-year multicentre, randomised con-
trolled trial (RCT) following a 2x2 factorial design com-
paring PA and dietary interventions with usual care in
CRC patients.
A 2x2 factorial design is chosen because it has the
advantage of testing both interventions with a smaller
sampler size when compared with the alternative of a
three parallel group design.
Treatment period and follow up
Dietary and PA interventions will be delivered over a
12 month period and participants will be followed up for
a further 12 months.
Baseline assessment will be conducted at the Univer-
sity of Hong Kong. All baseline measures will be made
prior to group allocation. An interim outcome assess-
ment will be performed six months after randomization.
Outcome/follow-up assessments will be made at 12, 18
and 24 months after randomization. Staff responsible foroutcome assessment will not deliver the intervention. All
outcome assessments will be subject to a strict protocol
with researchers blinded to group allocation.
All participants (including the usual care group) will
be given written, publicly-available general advice that
encourages healthy lifestyles.
Participants in the PA intervention group will have one
face-to-face intervention contact at the beginning followed
by fortnightly telephone contacts for 12 months. They will
also receive 12 stage-based information pamphlets and
four newsletters by mail and will attend four group meet-
ings during the 12-month intervention period.
Participants in the dietary intervention group will have
two face-to-face intervention contacts during the first
four months and fortnightly telephone contacts through-
out the 12 months. They will also receive 12 stage-based
information pamphlets and four newsletters by mail and
will attend four group meetings during the 12-month
intervention period.
The interventions will be delivered by trained research
staff and the research team members.
Primary outcome
To evaluate the acceptability and feasibility of two
behaviour interventions for CRC survivors intended to
improve cancer outcome. These interventions are de-
signed to:
1. Increase PA levels to improve general health and
cancer outcome;
2. Decrease consumption of a Western-pattern diet.
The PA target for improving general health is 30 minutes
of moderate-to-vigorous intensity PA (MVPA) five days
a week (equivalent to 10 MET-hours per week). The PA
target for improving cancer outcome is 60 minutes of
MVPA five days a week (equivalent to 18–20 MET-hours
per week).
The dietary targets are to limit weekly red or processed
meat intake to <5 servings and to limit daily refined grain
intake to two servings.
The primary outcome measure will be whether the PA
or dietary targets are met at the end of the 12-month
intervention.
Secondary outcomes
To assess the magnitude of PA and dietary change and
estimate the association of such changes with changes in
the underlying theoretical constructs (mechanisms of
behavioural change).
We will determine:
1. The degree and determinants of compliance to the
intervention.
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composition, physical fitness, quality of life and
mood), and any side effects (including nutritional
deficiency and PA-associated injury) of the
intervention.Measures/assessment instrument
Measures of all outcome points will be completed face-
to-face. Details of the outcomes to be collected at dif-
ferent time points and the instruments used are shown
in Table 1.Centre and participant selection
Participants will be recruited from the surgical and clinical
oncology departments of four public hospitals (Queen
Mary Hospital, Pamela Youde Nethersole Eastern Hospital,
Princess Margaret Hospital and Yan Chai Hospital) in three
regions of Hong Kong. The intervention will be delivered
in the three regional centres (Queen Mary Hospital on
Island West, Pamela Youde Nethersole Eastern Hospital on
Island East and Princess Margaret Hospital at Kowloon
West). The clinical collaborators of each site haveble 1 Outcome measures
Measures
imary outcome
target – general health Accelerometer
target – cancer outcome Accelerometer
etary target – red/processed meat FFQ [30]
etary target – refined grain FFQ [30]
condary outcome
agnitude of PA change Accelerometer
GPAQ [31]
agnitude of dietary change FFQ [30]
mpliance Intervention record; p
easurement of theoretical constructs Questionnaire
cilitators and barriers of intervention Questionnaire
Focus-group discussio
I, WHR Calibrated scales, stad
dy and visceral fat Bioelectrical impedanc
ysical fitness Six-minute ergometry
uality of life SF12 [32,33], FACT [34
ood HADS [35,36], PSS [37]
etary deficiency – caloric and protein intake FFQ [30]
etary associated anaemia CBC by blood test
- associated injury Direct questioning du
breviations: M-months post-randomization, PA-physical activity, BMI-body mass i
ysical activity questionnaire, SF12-Short Form 12 item, FACT-Functional Assessme
S-Perceived Stress Scale, CBC-complete blood count.established that the colorectal and oncology teams are
willing to participate in this trial.
Inclusion criteria
Histologically proven colorectal adenocarcinoma patients
above the age of 18 years within one year of completion
of main cancer treatment who are able to provide in-
formed consent.
Exclusion criteria
CRC patients who have persistent or recurrent disease at
the time of the recruitment, are receiving cancer treatment,
suffer from hereditary CRC syndrome(s), have known con-
traindication to PA, are unable to read Chinese, have
intakes of red/proceed meat less than five servings per
week and refined grains less than two servings daily, or
accumulate more than 300 minutes per week of MVPA.
Participant recruitment
Patients will be identified from the CRC Case Manage-
ment Programme conducted in each participating hospital.
Cancer diagnosis and treatment status will be confirmed
by medical record review.When
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
edometer, food diary 6 M, 12 M
0 M, 6 M, 12 M, 18 M, 24 M
6 M, 12 M
n Towards end of intervention
(last group meeting)
iometer; tape measure 0 M, 6 M, 12 M, 18 M, 24 M
e 0 M, 12 M, 24 M
0 M, 12 M, 24 M
] 0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
0 M, 6 M, 12 M, 18 M, 24 M
ring phone call Fortnightly during intervention, 6 M, 12 M
ndex, WHR-waist-hip ratio, FFQ-food frequency questionnaire, GPAQ-global
nt of Cancer Therapy, HADS-Hospital Anxiety and Depression Scale,
Table 2 Milestones for each HAPA stage of change
HAPA stage Milestones
Pre-intentional stage 1. Change in attitude regarding
behaviour change
2. Perceive behavioural health-link
3. Perceive social pressure for behavioural
change from significant others
Intentional stage 1. Intention to modify behaviour
2. Perceive behavioural control
3. Develop optimistic belief about ability
to deal with barriers
Actional stage 1. Goal setting and review of behavioural goals
2. Action planning
3. Self-monitoring of performance
4. Feedback
5. Develop coping strategies to deal with barriers
6. Behaviour maintenance
(relapse prevention and recovery)
Abbreviations: HAPA-Health Action Process Approach.
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ductory letter containing information about the study,
followed by an initial contact (phone or in person at the
clinic) by the Cancer Case Manager of each participating
hospital. Patients who express their interest will then be
approached by the research staff for further screening of
eligibility and informed consent if deemed eligible.
Informed consent
Those who state their interest in taking part will be given
any further information they require and, if eligible, invited
to the participating hospital to provide informed consent.
Registration
Data on individuals invited to participate in the trial,
whether they consent to be contacted by the research
staff, and their eligibility will be kept by the Cancer Case
Managers who initially contacted the potential partici-
pants. The research staff will also keep a log of any indi-
viduals who decline at the trial consent meeting. A
computerized case report form will be completed for
all consenting individuals. Details of a primary caregiver
(if applicable) will also be collected to facilitate partici-
pant follow-up. The research staff will use the trial data-
base to enter and store data on all eligible individuals.
Recruitment information will also be monitored at regu-
lar intervals by comparing this to the numbers being
approached and the numbers declining.
Withdrawal and loss to follow-up
Individuals have the right to withdraw consent for par-
ticipation in any aspect of this trial at any time. Their
medical care will not be affected at any time by declining
to participate in or withdrawing from the trial.
The research team will make every effort to minimize
the loss to follow-up. If a participant misses one follow-up,
we will try to re-arrange with them a session on at least
two further occasions. Participants will receive a travel
allowance for attending baseline and outcome assessment
at the study centre (the University of Hong Kong).
Trial intervention
The intervention groups
“Moving Bright, Eating Smart” is a personalised, multiple-
contact intervention programme based on the TPB [13]
and the HAPA [22] which guide interventions on health
self-regulation that involve motivation, volitional and
actional processes for adopting and maintaining health-
enhancing behaviours [22,27]. The HAPA addresses the
intention-behaviour gap and aims to identify and modify
the mechanism of behaviour change (mediators). The
objectives/milestones for each stage of change are shown
in Table 2.Physical activity intervention
The PA targets are:
a. General health target of 30 minutes of MVPA 5 days
a week (10 MET-hours per week)
b. Cancer outcome target of 60 minutes of MVPA
5 days a week (18–20 MET-hours per week).
During the first six months, participants will be asked to
increase PA progressively to achieve the general health
target with the aim of progressing towards the cancer out-
come target in the next six months. Our previous unpub-
lished research (Phase 0) indicated that the two most
preferred modes of PA intervention would be home-based
exercise and an incidental active lifestyle.
The PA intervention will consist of:
(1)One face-to-face motivational interview with
emphasis on instilling the belief in health and cancer
outcome improvement by increasing PA level, goal
setting, exploring PA options, exploring perceived
facilitators and barriers to PA change and
demonstrating the use of a pedometer for progress
monitoring;
(2)Fortnightly motivational phone calls for progress
monitoring, providing encouragement and
reinforcement as well as problem solving;
(3)Monthly HAPA-stage-of-change matched pamphlets
by mail providing information, practical tips and
suggested task to consolidate PA change;
(4)Quarterly newsletters by mail for experience sharing
among participants;
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support, demonstrating various PA options and
facilitating discussion on barriers to PA change.
All PA participants will be given a pedometer and
a monthly PA log as means of monitoring changes in
PA level.Dietary intervention
The dietary targets are:
(a)Less than five servings of red/processed meat
weekly; less than two servings of which will be
processed meat;
(b)Two servings of refined grains daily.
During the first six months, participants will be asked
to gradually reduce red/processed meat first, followed by
refined grains. They will be encouraged to replace red/
processed meat with other protein sources and refined
grains with wholegrain. In order to establish and en-
hance perceived self-efficacy to maximize the probability
of desired behavioural change, a staggered approach will
be adopted, focusing on reduction of red/processed meat
first. Strategies to reduce refined grain intake will be ini-
tiated within one month after a participant becomes an
“actor” of reduced red/processed meat. During the next
six months, participants will be expected to progress
towards the dietary targets as stated above.
Similar to the PA intervention, the dietary intervention
will consist of:
(1)Two face-to-face motivational interviews, one for
red/processed meat and another for refined grains;
(2)Fortnightly motivational phone calls;
(3)Monthly HAPA-stage-of-change matched
information pamphlets by mail;
(4)Quarterly newsletters by mail;
(5)Quarterly group meeting.
All participants in the dietary group will be given a food
diary with monthly dietary logs for monitoring changes
in the intakes of red/processed meat and refined grains. A
set of eating utensils will also be given to facilitate portion
size estimation.PA and dietary intervention
This group will receive, where possible, an integrated
version of both intervention components. This inte-
grated approach is necessary to avoid intervention over-
load (participant fatigue) in this particular group.
For all subjects in the intervention groups, the exact con-
tent and the pace of the intervention delivered will dependon the participants’ extant PA and dietary pattern, medical
co-morbidities, HAPA stage and individual preferences.
The usual care (control) group
Similar to those in the intervention groups, the usual care
participants will be mailed, at regular intervals, five pam-
phlets containing general advice encouraging a healthy
lifestyle, including eating a wide variety of food, eating
more fruit and vegetable, increasing physical activity level,
maintaining a normal body weight, quitting smoking and
avoiding alcohol abuse. The above mentioned information
is widely available in the public domains (websites of the
World Health Organization and the Department of Health
in Hong Kong).
Maintaining contact with these participants from the
baseline assessment to the various outcome assessments
is done to minimize loss to follow-up. Furthermore, this
practice would ensure that all participants receive some
lifestyle advice that at the moment is given on an ad hoc
basis. We anticipate that the effect of these pamphlets
alone would be small.
Figure 1 illustrates the participant pathway throughout
the trial.
Serious adverse events and adverse events
No serious adverse events (SAE) are anticipated. How-
ever, if any SAE occurs, this will be reported to the Insti-
tutional Review Boards and will also be drawn to the
immediate attention of the clinical collaborators of the
participating departments.
Participants receiving the dietary intervention will be
monitored to prevent specific nutrient deficiency includ-
ing inadequate caloric and protein intakes and iron-
deficiency anaemia due to inadequate red meat intake.
Participants receiving the PA intervention will be moni-
tored for PA-associated injury.
Statistical considerations
Randomisation
A randomisation schedule will be generated by block
randomisation with stratification by study centre and
stoma status. The block size will be decided and securely
kept by a randomiser who will not be involved in subject
recruitment. The randomisation will be managed
centrally by the randomiser. When an eligible patient
consents to participate in the study, the recruiter will
obtain the treatment code from a centralised access
restricted randomisation system.
Sample size
In the control arm, we do not expect that a sizable per-
centage of participants will achieve the behavioural
targets. Nevertheless, we conservatively assume that 10%
of them will reach the targeted levels at one year, which
Eligible patients will be sent introductory letter about the study followed by preliminary contact by case manager (est. n = 760)
Main inclusion: >18 year old patients with colorectal adenocarcinoma within 12 months of completion of main cancer treatment
Main exclusion: persistent/recurrent disease, current cancer treatment
Interested individuals will be contacted by research staff for eligibility screening; eligible patients will be invited to participating sites
for informed consent and baseline assessment (est. n = 456)
Random allocation to one of the three intervention groups or the usual care group
Intervention (n = 168) Usual care (n = 56)
Will receive 5 general leaflets on healthy lifestyle plus
“Moving Bright, Eating Smart” intervention programme
PA group
Pedometer for monitoring
1 face-to-face visit in the
first month
Do not wish to participate est. n = 304
Dietary group
Food diary & eating 
utensils for monitoring
2 face-to-face visits in the
first 4 months
PA & dietary group
Pedometer, food diary & 
eating utensils for monitoring
2 face-to-face visits in the 
first 4 months
Months 1 to 6
(1) Fortnightly motivational phone calls; (2) Monthly stage-matched information pamphlets; 
(3) Quarterly newsletters; (4) Quarterly group meetings
Interim assessment at 6 months post-randomization
Months 7 to 12
(1) Fortnightly motivational phone calls; (2) Monthly stage-matched information pamphlets; 
(3) Quarterly newsletters; (4) Quarterly group meetings
Assessment at 12 months post-randomization
(n = 151)       12 months follow-up                 (n = 50)
Assessment at 18 and 24 months post-randomization
Loss to follow
up est. n = 3
Loss to follow
up est. n = 3
Will receive 5 general leaflets on 
healthy lifestyle
Loss to follow
up est. n = 17
Figure 1 Participant flow chart.
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intervention effects. Although we are optimistic about
the intervention effect, based on our clinical experience,
we consider that a 10-20% improvement in the interven-
tion arm over the usual care would be regarded as mini-
mally significant for promoting the use of the intervention.
Hence, we assume an effect size of 15%. To achieve 80%
power with a 5% false positive error rate to detect this
effect size by a chi-square test, we need 50 subjects per cell
and thus 200 patients in total. Expecting a 10% dropout
rate, we will need to recruit 224 patients for the study. The
sample size should be sufficient when the improvement
is larger than expected.
Analysis
Main analysis
Efficacy of the dietary and PA interventions in helping
patients to reach the corresponding behavioural target
will be assessed by logistic regression analysis. Model
adequacy will be examined by the Hosmer-Lemeshow
goodness of fit test. The analysis will be performed on
two analysis sets, full and per-protocol, to examine the
sensitivity of results due to non-compliance. The full
analysis set includes all patients as randomised. Patients
with missing values will be taken as if they did not reach
the targeted level. The per-protocol set includes all
patients who complied with the intervention and have
no missing values. Conclusions will be made from the
results derived from the full analysis set, which is consis-
tent with the intention-to-treat principle. All analysis
will be adjusted for recruitment sites and stoma status.
Analysis of secondary outcomes will be performed by
mixed-effects analysis to account for extra covariance
from repeated measurements taken from a participant.
A 95% confidence interval will accompany all effect
estimates and a 5% level of significance will be used in
all significance tests.
Qualitative analysis
Focus-group discussions will be conducted in the last
quarterly group meeting investigating the facilitators and
barriers to both interventions. The discussion will be
audio-taped and contents will be transcribed. Data will
be systematically coded using content analysis and
analysed by comparing discussion of similar opinions to
form themes and at the same time note the deviant
opinions from the themes.
Data storage and retention
Data management will be handled by the Department
of Surgery of the University of Hong Kong with data
being held according to the International Conference on
Harmonisation (ICH) Good Clinical Practice (GCP) E6
Guideline and the Declaration of Helsinki. Data will beheld for a minimum of ten years from the completion
of the project.
Ethical approval, research governance and data access
Ethical approval was obtained from the Institutional Review
Board of the Hong Kong West Cluster, the Hospital
Authority in Hong Kong (Reference number: UW 12–478)
with other participating centres providing site-specific
approval (Island East reference number: HKEC-2012-068;
and Kowloon West reference number: KW/EX-13-002
(59–02)). The trial has been registered at the ClinicalTrials.
gov with the trial number of NCT01708824.
Study/trial sponsorship
The University of Hong Kong is the sponsor of this trial.
Discussion/rationale for the current study
This is the first PA and dietary intervention on CRC
survivors in an Asian population.
To date, there is insufficient information available from
the published literature as to the most effective way in pro-
moting lifestyle changes in CRC survivors. Moreover, none
of these interventions have been conducted in an Asian
population where the culture, eating habit, built environ-
ment and climate is typically different to most Western
populations. This knowledge gap shows the importance
of our study.
The latest WCRF recommendation states that cancer
survivors should follow the same lifestyle recommenda-
tions for cancer prevention. Our previous survey of 150
CRC survivors (unpublished data) showed that <4% of
our patients were current drinkers and their mean body
mass index and waist-hip ratio were 23.8±3.5 kg/m2 and
82.3±10.2 cm, respectively. These findings accentuate
the importance of testing the effect of changing PA and
diet as they are likely to be the only two modifiable
factors worthy of consideration for intervention in our
patient population.
In our study, we have chosen two PA targets: the general
health target which corresponds to the general public
health PA guideline of 10 MET-hours per week; and the
cancer outcome target based on the study by Meyerhardt
et al. [6] which suggested that a PA level of more than 18
MET-hours per week was required to significantly reduce
cancer mortality. The on-going CHALLENGE trial [38]
on CRC survivors also uses 20 MET-hours per week as
the PA target at 6 to 12 months of intervention. Having
two PA targets varying in difficulty and with correspond-
ing health benefits may provide encouragement to those
participants lacking self-efficacy for, or ability to, change.
Besides, a more recent study has noted measurable cancer
risk reductions associated with 6 to 12 MET-hours per
week of PA [39]. Therefore, given that the evidence is
rather inconclusive and the possibility of lower levels of
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cancer outcomes, it is important to evaluate the feasibility
of meeting this more moderate behavioural target. Further-
more, engagement in 10 MET-hours per week has been
associated with significant reduction in overall mortality
risk [40], risk of a range of non-communicable diseases
[41,42] and better quality of life in cancer survivors [43].
These are important non-trivial health outcomes for CRC
survivors as much as they are for the general population.
The study by Meyerhardt et al. [7] showed that the lowest
intake of a Western-pattern diet significantly reduced can-
cer mortality when compared to the highest intake. Our
previous survey (unpublished data) concluded that <1% of
the 150 CRC survivors studied consumed more than one
serving of sugary desserts daily. Therefore, the rounded-up
lowest intake levels of red/processed meat (5 servings per
week) and refined grains (2 servings daily) were adopted as
our dietary target.
The main proposed mechanism of PA and diet influen-
cing CRC outcome relates to energy balance [29]. Physical
inactivity and a Western-pattern diet shift energy balance
leading to hyperinsulinaemia, high insulin-like growth fac-
tor 1 (IGF-1) levels and insulin resistance [44-47] which
stimulate growth and inhibit apoptosis of micro-metastases
[47-49] leading to cancer recurrence and mortality [29].
The luminal effect of carcinogens derived from red and
processed meat is another possible mechanism associated
with colorectal carcinogenesis. With reduced intake of red/
processed meat, the reduced luminal effect of carcinogen
may result in the reduction of local recurrence, especially
for rectal cancer. Other potential mechanisms relating to
PA and diet are alteration in vitamin D, hormonal changes,
inflammation and immune modulation [29].
Our planned study follows the Medical Research Council
(MRC) framework for the design and evaluation of com-
plex interventions [50]. The design of this Phase 2 trial
is based on the TPB and HAPA as well as the findings of
our previous work including those from a literature review
[8], qualitative interviews and survey. The exact strategies
to be adopted and the pace of the intervention to be deliv-
ered will depend on the HAPA stage of an individual
subject, which will be determined monthly throughout the
12-month intervention.
The results of this Phase 2 trial will be key in estab-
lishing the feasibility of targeting the two behaviours (PA
and diet) and demonstrating the magnitude of behaviour
change. Such information will be essential in the design of
a subsequent larger and definitive Phase 3 RCT with CRC
outcome as a primary endpoint. By following the MRC
framework in designing and evaluating our intervention
systematically, we are in the best position to determine its
effectiveness in promoting lifestyle changes in CRC survi-
vors, and to determine whether this intervention would be
effective in improving CRC outcome.Abbreviations
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